Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied DNA Sciences Inc APDN

Technology Scientific & Technical Instruments
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates

Business Wire June 9, 2020

Applied DNA Provides Update on Linear-DNA COVID-19 Vaccine Candidates Development Program

Business Wire June 8, 2020

Applied DNA to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27

Business Wire May 21, 2020

Applied DNA Reports 2020 Fiscal Second Quarter Financial Results

Business Wire May 14, 2020

Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit

Business Wire May 14, 2020

Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET

Business Wire May 7, 2020

Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise

Business Wire May 6, 2020

Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit

Business Wire May 5, 2020

Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals

Business Wire May 4, 2020

Applied DNA Accepted Into U.S. FDA's Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging

Business Wire April 30, 2020

Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital

Business Wire April 21, 2020

Applied DNA Ships COVID-19 LinearDNA(TM) Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing

Business Wire April 15, 2020

Applied DNA to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference on May 5

Business Wire April 14, 2020

Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate

Business Wire April 2, 2020

Applied DNA Ships LinearDNA(TM) to Another Development Customer

Business Wire March 26, 2020

Applied DNA Files Provisional Patent Application for High Sensitivity COVID-19 Diagnostic Assay with U.S. Patent and Trademark Office

Business Wire March 24, 2020

Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customer

Business Wire March 20, 2020

Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection

Business Wire March 19, 2020

Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models

Business Wire March 18, 2020

Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA(TM) Vaccine Candidates Designed

Business Wire March 2, 2020